Source / episode info
- **Episode:**294
- **Title:**Divine Intervention Episode 294 – NBME Gastroenterology Series 2 (for all USMLEs).
- **Published:**2021-03-12
- Source:Episode page
One-liner
This episode provides a comprehensive review of GI pathology, covering celiac disease (duodenum/jejunum involvement), Crohn's disease (terminal ileum involvement), the pathophysiology and management of GERD, PPI indications for stress ulcers, Barrett's esophagus risk stratification, and Dapsone use in leprosy.
High-yield summary
- Celiac Disease: Characterized by villous atrophy, intraepithelial lymphocytosis, anti-tTG IgA, and HLA-DQ2/HLA-DQ8 association; typically affects the duodenum and jejunum.
- Crohn's vs Celiac: Crohn's disease classically involves the terminal ileum (leading to B12 deficiency and increased oxalate absorption risk); celiac disease spares the terminal ileum.
- PPI Use: PPIs are critical for prophylaxis in severe burns, high intracranial pressure (ICP), or chronic steroid use due to their ability to inhibit H+/K+ ATPase pumps, preventing stress/Cushing's ulcers.
- GERD Management: Initial management involves lifestyle changes and a therapeutic trial of PPIs; if symptoms persist, EGD is required, but for older patients (>50) with long-standing GERD, skip the initial PPI trial and proceed directly to EGD.
- Barrett's Esophagus: Represents intestinal metaplasia (goblet cells) in the lower esophagus due to chronic acid exposure; this condition significantly increases the risk of esophageal adenocarcinoma.
- Dapsone Therapy: Used for dermatitis/erythrodermic lupus, prophylaxis against Pneumocystis pneumonia (PCP), and is a core component of triple therapy for leprosy (with Rifampin and Clofazimine).
Learning objectives
- Differentiate the clinical and pathological findings between Celiac disease and Crohn's disease.
- Apply knowledge of PPI indications for prophylaxis in various high-risk states (burns, ICP, steroids).
- Interpret endoscopic findings suggestive of Barrett's esophagus and understand its associated malignancy risk.
- Outline the appropriate diagnostic workup sequence for chronic GERD symptoms.
- Recall the mechanism of action and clinical uses of Dapsone in infectious disease and dermatology.